Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders

Diabetes Care

Volumn 21, Issue 10, 1998, Pages 1759-1763

  Katsura, Yoshiya ^a   Okano, Tadashi ^a   Noritake, Masayuki ^a   Kosano, Hlroshi ^b   Nlshlgori, Hldeo ^b   Kado, Seijiro ^a   Matsuoka, Takeshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RETINA NEOVASCULARIZATION; RETINOPATHY; VASCULAR SMOOTH MUSCLE; VITREOUS BODY;

DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; HEPATOCYTE GROWTH FACTOR; HUMANS; LYMPHOKINES; RETINAL DETACHMENT; RETINAL DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITREOUS BODY;

EID: 0031685823     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.10.1759     Document Type: Article

References (22)

1. Sivalingham A, Kenney J, Brown G, Benson W, Donoso L: Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 108:869-872, 1990
2. Grant M, Russell B, Fitzgerald C, Merimee TJ: Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes 35:416-420, 1986
3. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Lösche C, Röllmann R, Schatz H: Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding protein 2 and 3, increase in neovascular eye disease: studies in nondiabetic and diabetic subjects. J Clin Invest 92:2620-2625, 1993
4. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
5. Adamis AP, Miller JW, Bemal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450, 1994
6. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, Nakamura T, Ogihara T: Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 215:483-488, 1995
7. Bussolino F, Di Renzo MF, Ziehe M, Bocchietto E, Olivero M, Naldini L, Guandino G, Tamagnone L, Coffer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629-641, 1992
8. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T: A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 28:409-413, 1996
9. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T, Ogihara T: Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 14:1067-1072, 1996
10. Matsumoto K, Nakamura T: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119:591-600, 1996
11. Jeffers M, Rong S, Woude GF: Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 74:505-513, 1996
12. Naldini L, Weidner KM, Vagna E, Gaudino G, Bardeli A, Ponzetto C, Narsimhan RP, Hartman G, Zarnegar R, Michalopoulos GK, Birchmeier W, Comoglio PM: Scatter factor and hepatocytes growth factor are indistinguishable ligands for the MET receptor. EMBO J 10:2867-2878, 1991
13. Stoker M, Gherardi E, Ferryman M, GrayJ: Scatter factor is a fibroblast-derived modulator of epithelial cell. Nature 327:239-242, 1987
14. Li Q, Weng J, Mohan R, Bennett G, Schwall R, Wang Z, Tabor K, Kim J, Margrave S, Cuevas K, Wilson S: Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci 37:727-739, 1996
15. Weng J, Liang Q, Nohan R, Li Q, Wilson S: Hepatocyte growth factor, keratinocyte growth factor, and other growth factor-receptor systems in the lens. Invest Ophthalmol Vis Sci 38:1543-1554, 1997
16. Burgos R. Simó R, Audí L, Mateo C, Mesa J, García- Ramírez M, Carrascosa A: Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diobetologia 40:1107-1109, 1997
17. Arakaki N, Kawakami S, Nakamura O, Ohnishi T, Miyazaki H, Ishii T, Tsubouchi H, Daikuhara Y: Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 22:1728-1734, 1995
18. Mizuno K, Inoue H, Hagiya M, Shimizu S, Nose T, Shimohigashi Y, Nakamura T: Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem 269:1131-1136, 1994
19. Masumoto A, Yamamoto N: Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. Biochem Biophys Res Commun 174:90-95, 1991
20. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of growth factor activities. Cell 64:867-869, 1991
21. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36-47, 1997
22. Mathews MK, Merges C, McLeod DS, Lutty GA: Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy Invest Ophthalmol Vis Sci 38:2729-2741, 1997